Amarin Corp Plc (AMRN)

[alm2]

rose
Sensible questions ....

But they can be directed also with other BP in mind not just Pfizer

So a stab at some answers .....

Amarin a steal ???? - with a share price of 5 which has been roughly where we have been running for a year many would suggest the BO cost is presently and has been for some time such to encourage a steal
Would a cost equivalent to10 ps take it though ?
Do big shareholders / the board think it worth more- at least 15 - I suspect so
But to attain that level does not litigation hangover fog the air as to USA market and as European market it is only just setting up - and other usage of V may yet take shape -so BP can sit on hands for a while and watch

As to GIA - Amarin will until it is not - no choice - but the right money buys any company !! However over time much can happen to improve the companies position and maybe move the needle

My view is that KM and the company are way to quiet - but time required to get ducks in a row

In a few months - maybe by 2022 we will start to hear a concerted noise from Amarin

rafs Pfizer post says it all !!!

As to HLS -is no harm to Pfizer but it does give hands on selling of the drug as a precursor to BO if they wish or other possible arrangements

It does Amarin no harm either

Alm